US 12,121,434 B2
Prosthetic valves and related inventions
Robert Vidlund, Forest Lake, MN (US); Kemal Schankereli, Stillwater, MN (US); Lucian Lozonschi, Madison, WI (US); and Georg Lutter, Kiel (DE)
Assigned to Tendyne Holdings, Inc., St. Paul, MN (US)
Filed by Tendyne Holdings, Inc., St. Paul, MN (US)
Filed on Sep. 8, 2022, as Appl. No. 17/930,661.
Application 15/183,943 is a division of application No. 14/237,023, granted, now 9,480,559, issued on Nov. 1, 2016, previously published as PCT/US2012/050579, filed on Aug. 13, 2012.
Application 17/930,661 is a continuation of application No. 17/832,596, filed on Jun. 4, 2022.
Application 17/832,596 is a continuation of application No. 17/574,647, filed on Jan. 13, 2022, granted, now 11,382,737, issued on Jul. 12, 2022.
Application 17/574,647 is a continuation of application No. 17/402,754, filed on Aug. 16, 2021, granted, now 11,311,374, issued on Apr. 26, 2022.
Application 17/402,754 is a continuation of application No. 17/231,085, filed on Apr. 15, 2021, granted, now 11,135,055, issued on Oct. 5, 2021.
Application 17/231,085 is a continuation of application No. 16/594,263, filed on Oct. 7, 2019, granted, now 11,123,180, issued on Sep. 21, 2021.
Application 16/594,263 is a continuation of application No. 15/829,091, filed on Dec. 1, 2017, granted, now 10,639,145, issued on May 5, 2020.
Application 15/829,091 is a continuation of application No. 15/183,943, filed on Jun. 16, 2016, granted, now 9,833,315, issued on Dec. 5, 2017.
Claims priority of provisional application 61/615,264, filed on Mar. 24, 2012.
Claims priority of provisional application 61/564,462, filed on Nov. 29, 2011.
Claims priority of provisional application 61/523,134, filed on Aug. 12, 2011.
Claims priority of provisional application 61/522,468, filed on Aug. 11, 2011.
Claims priority of provisional application 61/522,476, filed on Aug. 11, 2011.
Claims priority of provisional application 61/522,542, filed on Aug. 11, 2011.
Claims priority of provisional application 61/522,450, filed on Aug. 11, 2011.
Prior Publication US 2023/0000619 A1, Jan. 5, 2023
Int. Cl. A61F 2/24 (2006.01); A61L 27/34 (2006.01); A61L 27/36 (2006.01); A61L 33/00 (2006.01); C08L 67/04 (2006.01); A61B 17/04 (2006.01); A61B 17/064 (2006.01)
CPC A61F 2/2412 (2013.01) [A61F 2/2409 (2013.01); A61F 2/2418 (2013.01); A61F 2/2427 (2013.01); A61L 27/34 (2013.01); A61L 27/3625 (2013.01); A61L 27/3629 (2013.01); A61L 33/0011 (2013.01); C08L 67/04 (2013.01); A61B 17/0401 (2013.01); A61B 2017/0404 (2013.01); A61B 17/064 (2013.01); A61B 17/0644 (2013.01); A61F 2/2436 (2013.01); A61F 2/2457 (2013.01); A61F 2210/0004 (2013.01); A61F 2210/0014 (2013.01); A61F 2220/0008 (2013.01); A61F 2220/005 (2013.01); A61F 2220/0058 (2013.01); A61F 2220/0091 (2013.01); A61F 2230/0013 (2013.01); A61F 2230/0034 (2013.01); A61F 2230/005 (2013.01); A61F 2230/0054 (2013.01); A61F 2230/0067 (2013.01); A61F 2230/0091 (2013.01); A61F 2310/00023 (2013.01); A61F 2310/00077 (2013.01); A61L 2400/16 (2013.01); A61L 2430/20 (2013.01)] 17 Claims
OG exemplary drawing
 
1. A method of treating tricuspid valve regurgitation in a patient, the method comprising:
advancing a delivery catheter into or adjacent to a native tricuspid valve of the patient, the native tricuspid valve separating a right atrium from a right ventricle of the patient, the delivery catheter containing a prosthetic heart valve in a collapsed condition during the advancing, the prosthetic heart valve including a stent, a leaflet assembly supported by the stent, and a flexible gasket coupled to a ventricular end of the stent and positioned around an exterior of the stent;
while the delivery catheter is in or adjacent to the native tricuspid valve of the patient, beginning to deploy the gasket from the delivery catheter; and
after beginning to deploy the gasket from the delivery catheter, advancing the prosthetic heart valve through the native tricuspid valve until the gasket contacts an annulus of the native tricuspid valve to stop the prosthetic heart valve from traveling further through the native tricuspid valve,
wherein the gasket is coupled to the stent at a joint at or near the ventricular end of the stent.